Yahoo
LSE - Delayed Quote GBp

Convatec Group PLC (CTEC.L)

244.40 +1.20 (+0.49%)
At close: October 30 at 4:47:03 PM GMT
Chart Range Bar
Loading chart for CTEC.L
  • Previous Close 243.20
  • Open 244.00
  • Bid 244.20 x --
  • Ask 244.60 x --
  • Day's Range 243.00 - 246.80
  • 52 Week Range 193.00 - 259.30
  • Volume 5,428,717
  • Avg. Volume 8,153,054
  • Market Cap (intraday) 4.673B
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) 48.88
  • EPS (TTM) 0.05
  • Earnings Date Aug 4, 2026
  • Forward Dividend & Yield 0.06 (2.27%)
  • Ex-Dividend Date Aug 20, 2026
  • 1y Target Est 300.28

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

www.convatecgroup.com

10,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

CTEC.L
0.52%
FTSE 100 (^FTSE)
8.04%

1-Year Return

CTEC.L
0.77%
FTSE 100 (^FTSE)
9.94%

3-Year Return

CTEC.L
20.47%
FTSE 100 (^FTSE)
46.43%

5-Year Return

CTEC.L
14.43%
FTSE 100 (^FTSE)
48.25%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY22
Revenue 522.25M
Earnings --
Profit Margin 0.00%

Q3

FY21

Q4

FY21

Q1

FY22

Q2

FY22

0
100M
200M
300M
400M
500M
0.0%

Analyst Insights

View More

Analyst Price Targets

228.70
300.28 Average
244.40 Current
372.59 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.98%

  • Return on Assets (ttm)

    6.72%

  • Return on Equity (ttm)

    7.65%

  • Revenue (ttm)

    2.49B

  • Net Income Avi to Common (ttm)

    124M

  • Diluted EPS (ttm)

    0.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    92M

  • Total Debt/Equity (mrq)

    121.83%

  • Levered Free Cash Flow (ttm)

    182.78M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: